Kezar Life Sciences Inc (KZR)
0.9015
0.00 (0.00%)
USD |
NASDAQ |
Mar 28, 16:00
0.9189
+0.02
(+1.93%)
After-Hours: 20:00
Kezar Life Sciences Cash from Financing (TTM): 0.638M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.638M |
September 30, 2023 | 1.085M |
June 30, 2023 | 1.227M |
March 31, 2023 | 79.17M |
December 31, 2022 | 127.86M |
September 30, 2022 | 226.71M |
June 30, 2022 | 228.74M |
March 31, 2022 | 150.70M |
December 31, 2021 | 112.58M |
September 30, 2021 | 13.55M |
June 30, 2021 | 13.30M |
March 31, 2021 | 57.01M |
December 31, 2020 | 99.64M |
Date | Value |
---|---|
September 30, 2020 | 99.40M |
June 30, 2020 | 97.45M |
March 31, 2020 | 53.64M |
December 31, 2019 | 0.272M |
September 30, 2019 | 0.197M |
June 30, 2019 | -0.898M |
March 31, 2019 | 77.89M |
December 31, 2018 | 77.91M |
September 30, 2018 | 77.91M |
June 30, 2018 | 86.34M |
March 31, 2018 | 49.78M |
December 31, 2017 | 49.76M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.898M
Minimum
Jun 2019
228.74M
Maximum
Jun 2022
72.01M
Average
67.45M
Median
Cash from Financing (TTM) Benchmarks
Tonix Pharmaceuticals Holding Corp | 3.032M |
NovaBay Pharmaceuticals Inc | 4.971M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |